Blood_Glucose_Monitoring_Biomed_Animated

BIOMEDICAL SCIENCE • UNIVERSITY PRESENTATION

Application & Utility of Blood Glucose Monitoring

From a finger-stick number to real-time clinical decision-making


BGM → CGM → ACTION

Capillary blood glucose • continuous glucose monitoring • clinical translation

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

1

1 / 9
volgende
Slide 1: Slide
newEditor

In deze les zitten 9 slides, met tekstslides.

Dit is niet oké

Onderdelen in deze les

BIOMEDICAL SCIENCE • UNIVERSITY PRESENTATION

Application & Utility of Blood Glucose Monitoring

From a finger-stick number to real-time clinical decision-making


BGM → CGM → ACTION

Capillary blood glucose • continuous glucose monitoring • clinical translation

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

1

01 • WHY MONITOR?

Glucose is a dynamic biomarker

A single value is useful; a pattern is actionable.

POST-MEAL SPIKE

Meals can expose hidden excursions.

HYPOGLYCAEMIA

Low readings can trigger rapid action.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

2

02 • TECHNOLOGY

Two complementary monitoring approaches

Capillary BGM gives a point-in-time measurement; CGM adds direction and context.


CAPILLARY BGM

Finger-stick → blood sample → meter

Fast, practical, and essential as a backup when CGM is unavailable or uncertain.


CONTINUOUS GLUCOSE MONITORING

Sensor → interstitial glucose → trend data

Shows trajectories, alerts and metrics such as Time in Range (TIR).

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

3

03 • CLINICAL UTILITY

Where monitoring changes decisions

The value is not the number alone — it is what the number enables.

INSULIN TITRATION

Adjust basal / bolus therapy using glucose patterns.

HYPOGLYCAEMIA

Detect, prevent and treat low glucose.

NUTRITION & ACTIVITY

See responses to meals and exercise.

SAFETY

Support decisions around illness and critical tasks.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

4

04 • CLINICAL METRICS

CGM turns glucose into a time series

Three metrics make the data easier to interpret.


TIME IN RANGE

70–180 mg/dL (3.9–10.0 mmol/L)

How long glucose stays in the target zone.


TIME BELOW RANGE

<70 mg/dL (<3.9 mmol/L)

Highlights hypoglycaemia burden.


TIME ABOVE RANGE

>180 mg/dL (>10.0 mmol/L)

Shows hyperglycaemia burden.

A 10–14 day CGM assessment with adequate wear can support clinical assessment of glycaemic patterns.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

5

05 • BEYOND ROUTINE DIABETES CARE

Applications across biomedicine

Monitoring is increasingly connected to physiology, treatment and digital health.


HOSPITAL CARE

Point-of-care glucose supports insulin protocols and acute care.


PREGNANCY

CGM can support glycaemic goals in diabetes during pregnancy.


SPORT & EXERCISE

Monitoring helps identify exercise-related glucose changes.


DIGITAL HEALTH

Apps + CGM data can enable remote review and coaching.


RESEARCH

Dense glucose profiles reveal variability that HbA1c alone can miss.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

6

06 • LIMITATIONS

More data ≠ perfect data

Good biomedical practice means knowing when the measurement may mislead.

INTERSTITIAL LAG

CGM measures interstitial glucose; values can lag during rapid change.

ACCURACY / INTERFERENCE

Meters and sensors can be affected by device factors or interfering substances.

SKIN & USABILITY

Adhesion, irritation, alarms and device burden affect sustained use.

CLINICAL CONFIRMATION

If the reading conflicts with symptoms or context, confirm appropriately.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

7

07 • TAKE-HOME MESSAGE

Monitor → interpret → act

Blood glucose monitoring is a measurement system — not just a test.

MEASURE

BGM / CGM

INTERPRET

Pattern + trend

ACT

Therapy / lifestyle

REVIEW

Outcome + safety

Best practice combines accurate measurement, patient-centred technology, clinical context and informed action.

2026 framing: BGM remains essential; CGM increasingly adds continuous context and actionable trends.

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

8

REFERENCES

Selected evidence & guidance

Use these sources in your speaker notes / reference list.

American Diabetes Association. Standards of Care in Diabetes—2026. Section 7: Diabetes Technology.

diabetesjournals.org/care • 2026

American Diabetes Association. Standards of Care in Diabetes—2025. Section 6: Glycemic Goals and Hypoglycemia.

diabetesjournals.org/care • 2025

NICE NG17. Type 1 diabetes in adults: diagnosis and management — recommendations on CGM and self-monitoring.

nice.org.uk/guidance/NG17

BIOMEDICAL SCIENCE • BLOOD GLUCOSE MONITORING

9